More Transparency, Fewer Kickbacks for Doctors
In today’s NY Times, Gardiner Harris reports on renewed interest by federal prosecutors in going after doctors who accept illegal kickbacks from drug and device manufacturers in return for using their products. The Department of Health and Human Services is concerned about “marketing tactics that enrich doctors but increase health care costs and sometimes endanger [...]
Outsourcing of Drug Trials Raises Concerns
Today’s NY Times discusses the good and the potentially bad when it comes to conducting trials of new drugs outside of the United States. Subjects in developing countries may be rushing to sign up and disregarding their own safety. Populations in some other countries may be so physically different from Americans that results of testing may [...]
News You Can Use: Voir Dire for Drug and Device Products Cases
The folks at the Drug and Device Law blog share their insights into how lawyers must take the negative press constantly swirling around the FDA into account while engaged in jury selection. They also welcome your suggestions.